as on January 28, 2026 at 9:37 pm IST
Day's Low
Day's High
5.29%
Downside
-1.18%
Upside
52 Week's Low
52 Week's High
4.12%
Downside
2105.88%
Upside
Check Lyra Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.1M
EPS (TTM)
-25.66
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.2
Industry PE ratio
0PEG Ratio
0EBITDA
-31.9M
Revenue (TTM)
600.0K
Profit Margin
0.00%
Return On Equity TTM
-404.48%
Track how Lyra Therapeutics Inc P/E has moved over time to understand its valuation trends.
Lyra Therapeutics Inc in the last 5 years
Lowest (-189.81x)
June 30, 2021
Industry (0.00x)
January 28, 2026
Today (-0.20x)
January 28, 2026
Highest (-0.83x)
September 30, 2025
Today’s Price to Earnings Ratio: -0.20x
Compare market cap, revenue, PE, and other key metrics of Lyra Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.1M | -99.68% | -0.2 | 0.00% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Lyra Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lyra Therapeutics Inc investment value today
Current value as on today
₹24,574
Returns
Returns from Lyra Therapeutics Inc Stock
Dollar Returns*
₹5,974 (+5.97%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Lyra Therapeutics Inc. Average target price of $11.5
Get share price movements and forecasts by analysts on Lyra Therapeutics Inc.
What analysts predicted
85.22%UPSIDE
Target Price
$11.5
Current Price
$1.7
Analyzed by
12 Analysts
Target
$11.50
Lyra Therapeutics Inc target price $11.5, a slight upside of 85.22% compared to current price of $1.7. According to 12 analysts rating.
Investment in Lyra Therapeutics Inc Shares on INDmoney has grown by 491.66% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:491.66% versus previous 30 day period
Search interest for Lyra Therapeutics Inc Stock has increased by 440% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:440% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 6 quarters, -48.13M → -5.98M (in $), with an average increase of 76.2% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 128.1%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 129.8%
Revenue Fall
![]()
Revenue is down for the last 4 quarters, 209.0K → 25.0K (in $), with an average decrease of 32.9% per quarter
Price Dip
![]()
In the last 7 days, LYRA stock has moved down by -24.7%
| Organisation | Lyra Therapeutics Inc |
| Headquarters | 480 Arsenal Way, Watertown, MA, United States, 02472 |
| Industry | Health Technology |
| CEO | Dr. Carmichael S. Roberts Jr., M.B.A., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Allison Nance | Senior Vice President of Regulatory Affairs |
Dr. Elazer R. Edelman FACC, M.D., Ph.D. | VP of Finance & Risk |
Dr. Carmichael S. Roberts Jr., M.B.A., Ph.D. | Co-Founder |
Mr. Ronan P. O'Brien J.D. | Chief Legal Officer |
Ms. Vineeta Belanger Ph.D. | Senior Vice President of Clinical Affairs |
Dr. Robert Kern M.D. | Chief Clinical Advisor |
Ms. Gloria Cosgrove | Senior Vice President of Quality & Technical Operations |
Lyra Therapeutics Inc share price today is $1.7 as on . Lyra Therapeutics Inc share today touched a day high of $1.68 and a low of $1.61.
Lyra Therapeutics Inc share touched a 52 week high of $37.5 on and a 52 week low of $1.63 on . Lyra Therapeutics Inc stock price today i.e. is trending at $1.7,which is 95.47% down from its 52 week high and 4.29% up from its 52 week low.
Lyra Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Lyra Therapeutics Inc (LYRA) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Lyra Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lyra Therapeutics Inc share’s latest price of $1.7 as on January 28, 2026 at 9:37 pm IST, you will get 5.8824 shares of Lyra Therapeutics Inc. Learn more about
fractional shares .
Lyra Therapeutics Inc stock has given -99.68% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?